Paper39690293
Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.
Liu S and 12 others. Mol Cell Biochem, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation. Papers, record 39690293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39690293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interleukin-22 promotes endometrial carcinoma cell proliferation and cycle progression via ERK1/2 and p38 activation.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukins | Major topic |
| Endometrial Neoplasms | Major topic |
| Cell Proliferation | Major topic |
| MAP Kinase Signaling System | Major topic |
| p38 Mitogen-Activated Protein Kinases | Major topic |
| Mitogen-Activated Protein Kinase 3 | Major topic |
| Mitogen-Activated Protein Kinase 1 | Major topic |
| Neoplasm Proteins | Major topic |
| Female | |
| Humans | |
| Interleukin-22 | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Middle Aged | |
| Mice, Nude |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21JCYBJC01080 | Tianjin Municipal Science and Technology Program | PubMed | ||
| TJWJ2022XK003 | Tianjin Municipal Health Commission | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30539314 | Interleukin-22 promotes tumor angiogenesis. | Angiogenesis | 2019 | https://conductscience.org/library/papers/30539314 | PubMed |
| 2 | 19238148 | Cell cycle, CDKs and cancer: a changing paradigm. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19238148 | PubMed |
| 3 | 15122762 | Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. | Hepatology | 2004 | https://conductscience.org/library/papers/15122762 | PubMed |
| 4 | 16934487 | The Myc oncoprotein as a therapeutic target for human cancer. | Semin Cancer Biol | 2006 | https://conductscience.org/library/papers/16934487 | PubMed |
| 5 | 34300224 | The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer. | J Clin Med | 2021 | https://conductscience.org/library/papers/34300224 | PubMed |
| 6 | 27272709 | Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway. | Sci Rep | 2016 | https://conductscience.org/library/papers/27272709 | PubMed |
| 7 | 12138194 | Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/12138194 | PubMed |
| 8 | 31843590 | Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31843590 | PubMed |
| 9 | 27473926 | Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. | Gynecol Oncol | 2016 | https://conductscience.org/library/papers/27473926 | PubMed |
| 10 | 36531027 | The roles and clinical applications of interleukins in endometrial carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36531027 | PubMed |
| 11 | 24378801 | Therapeutic opportunities of the IL-22-IL-22R1 system. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/24378801 | PubMed |
| 12 | 36091010 | IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix. | Front Immunol | 2022 | https://conductscience.org/library/papers/36091010 | PubMed |
| 13 | 22922995 | STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma. | Int J Oncol | 2012 | https://conductscience.org/library/papers/22922995 | PubMed |
| 14 | 12087100 | Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12087100 | PubMed |
| 15 | 10657629 | Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. | J Immunol | 2000 | https://conductscience.org/library/papers/10657629 | PubMed |
| 16 | 10954742 | Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10954742 | PubMed |
| 17 | 35874717 | Immunotherapy: Reshape the Tumor Immune Microenvironment. | Front Immunol | 2022 | https://conductscience.org/library/papers/35874717 | PubMed |
| 18 | 23379788 | IL-22 is related to development of human colon cancer by activation of STAT3. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23379788 | PubMed |
| 19 | 25706098 | Interleukin-22: immunobiology and pathology. | Annu Rev Immunol | 2015 | https://conductscience.org/library/papers/25706098 | PubMed |
| 20 | 35409206 | Metastasis and MAPK Pathways. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409206 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942215 | Fluoxetine Is Associated with Reduced Cell Viability and Decreased pERK1/2 Immunoreactivity in Ishikawa Endometrial Cancer Cells In Vitro: An Exploratory Study. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942215 | PubMed |
| 41661469 | Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/41661469 | PubMed |
| 41594384 | Unveiling the Genomic Landscape of Yan Goose (Anser cygnoides): Insights into Population History and Selection Signatures for Growth and Adaptation. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/41594384 | PubMed |
| 41179292 | A Machine-Learning Prognostic Model for Colorectal Cancer Using a Complement-Related Risk Signature. | Oncol Res | 2025 | https://conductscience.org/library/papers/41179292 | PubMed |
| 40806980 | EphA5 Expression Predicts Better Survival Despite an Association with Proliferative Activity in Endometrial Cancer. | J Clin Med | 2025 | https://conductscience.org/library/papers/40806980 | PubMed |
| 40508002 | Endometriosis: An Immunologist's Perspective. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508002 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CCNE1 | 898 | PubTator's text mining | https://conductscience.org/library/genes/898 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| CDK6 | 1021 | PubTator's text mining | https://conductscience.org/library/genes/1021 | NCBI Gene |
| IL22 | 50616 | PubTator's text mining | https://conductscience.org/library/genes/50616 | NCBI Gene |
| IL22RA1 | 58985 | PubTator's text mining | https://conductscience.org/library/genes/58985 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39690293
GET https://conductscience.org/api/papers/v1/39690293/references?page=2